Why the study?
Marked non-selective proteinuria in nephrotic syndrome may correlate with reduced anticoagulant drug concentrations, raising uncertainty about the most appropriate anticoagulant choice.
Does rivaroxaban with plasma concentration monitoring effectively treat pulmonary embolism and renal vein thrombosis in a patient with nephrotic syndrome?
Does rivaroxaban with plasma concentration monitoring effectively treat pulmonary embolism and renal vein thrombosis in a patient with nephrotic syndrome?
Rivaroxaban, guided by plasma concentration monitoring, may be an effective treatment for pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome despite concerns of reduced drug concentration due to proteinuria.
Should not yet change DOAC choice in NS-related VTE; leaves open whether rivaroxaban-level monitoring overcomes proteinuria-related underdosing.
This case report presents a scenario of pulmonary embolism (PE) and renal vein thrombosis (RVT) in a young patient with a recent diagnosis of nephrotic syndrome (NS). The presence of a clinical condition characterised by a marked non-selective proteinuria, which may correlate with reduced drug concentration, has raised doubts about the most appropriate anticoagulant therapeutic choice. A 34-year-old male patient presented to the emergency department with dyspnea, chest pain and hypotension. Two days prior, the patient had undergone a renal biopsy for a recent NS finding. An urgent CT scan revealed a right pulmonary embolism and inferior left renal vein thrombus, prompting immediate anticoagulant therapy. The patient was discharged on rivaroxaban. The presence of NS and the consequent concern regarding potential decreased drug concentration led us to monitor rivaroxaban plasma concentrations during the treatment period. Monitoring showed a strong correlation between the extent of proteinuria and the drug concentration. At the 4-month follow-up after discharge from the hospital, the patient was performing normal daily activities without limitations, and angio-CT showed complete resolution of renal and pulmonary thrombotic formations. In this clinical case, pulmonary embolism associated with renal vein thrombosis in a patient with a recent diagnosis of NS was managed with rivaroxaban with a good clinical outcome.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: